Determinants of quinolone versus trimethoprim-sulfamethoxazole use for outpatient urinary tract infection
- PMID: 22232276
- PMCID: PMC3294920
- DOI: 10.1128/AAC.05321-11
Determinants of quinolone versus trimethoprim-sulfamethoxazole use for outpatient urinary tract infection
Abstract
Quinolones are increasingly favored over trimethoprim-sulfamethoxazole (TMP-SMX) for empirical treatment of uncomplicated urinary tract infection (UTI). This is associated with increasing resistance toward this broad-spectrum group of antibiotics. Our objective is to describe the prescribing patterns and identify determinants of the choice between TMP-SMX and quinolones for outpatient UTI treatment in Switzerland. An ongoing national Sentinel surveillance system was used to study 11,799 antibiotic prescriptions for UTI in adult outpatients and associated physician and patient factors between 2006 and 2008, to compare the prescription of quinolones versus that of TMP-SMX for treatment of UTI. Most UTI episodes were diagnosed as cystitis (90%). TMP-SMX was prescribed for one-fifth (22%) of UTIs. Independent predictors for prescribing quinolones were pyelonephritis and physicians with low thresholds for prescribing antibiotics for upper respiratory tract infections ("high prescribers"), whereas female patients were more likely to receive TMP-SMX. High-prescribing physicians also more often cared for patients who themselves favor antibiotic treatment (P < 0.001). Quinolones are commonly prescribed to outpatients with UTI. Nonclinical factors influence the choice of quinolones versus TMP-SMX, which may provide opportunities for interventions to improve prescribing patterns and control quinolone resistance.
Figures

Similar articles
-
Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections.Ann Intern Med. 2001 Jul 3;135(1):41-50. doi: 10.7326/0003-4819-135-1-200107030-00012. Ann Intern Med. 2001. PMID: 11434731 Review.
-
Outcomes associated with trimethoprim/sulphamethoxazole (TMP/SMX) therapy in TMP/SMX resistant community-acquired UTI.Int J Antimicrob Agents. 2002 Jun;19(6):554-6. doi: 10.1016/s0924-8579(02)00104-8. Int J Antimicrob Agents. 2002. PMID: 12135847 Review.
-
The current management strategies for community-acquired urinary tract infection.Infect Dis Clin North Am. 2003 Jun;17(2):303-32. doi: 10.1016/s0891-5520(03)00004-7. Infect Dis Clin North Am. 2003. PMID: 12848472 Review.
-
Addressing antibiotic resistance.Dis Mon. 2003 Feb;49(2):99-110. doi: 10.1067/mda.2003.10. Dis Mon. 2003. PMID: 12601340 Review.
-
A Seven-Day Course of TMP-SMX May Be as Effective as a Seven-Day Course of Ciprofloxacin for the Treatment of Pyelonephritis.Am J Med. 2017 Jul;130(7):842-845. doi: 10.1016/j.amjmed.2017.01.025. Epub 2017 Feb 16. Am J Med. 2017. PMID: 28216442 Free PMC article.
Cited by
-
A single center observational study on emergency department clinician non-adherence to clinical practice guidelines for treatment of uncomplicated urinary tract infections.BMC Infect Dis. 2016 Nov 4;16(1):638. doi: 10.1186/s12879-016-1972-6. BMC Infect Dis. 2016. PMID: 27814677 Free PMC article.
-
Susceptibility to first choice antimicrobial treatment for urinary tract infections to Escherichia coli isolates from women urine samples in community South Brazil.Braz J Infect Dis. 2022 May-Jun;26(3):102366. doi: 10.1016/j.bjid.2022.102366. Epub 2022 May 18. Braz J Infect Dis. 2022. PMID: 35594950 Free PMC article.
-
Trimethoprim and other nonclassical antifolates an excellent template for searching modifications of dihydrofolate reductase enzyme inhibitors.J Antibiot (Tokyo). 2020 Jan;73(1):5-27. doi: 10.1038/s41429-019-0240-6. Epub 2019 Oct 2. J Antibiot (Tokyo). 2020. PMID: 31578455 Free PMC article. Review.
-
Uncomplicated Urinary Tract Infections and Antibiotic Resistance-Epidemiological and Mechanistic Aspects.Antibiotics (Basel). 2014 Jul 22;3(3):341-52. doi: 10.3390/antibiotics3030341. Antibiotics (Basel). 2014. PMID: 27025749 Free PMC article. Review.
-
Sex- and age-specific trends in antibiotic resistance patterns of Escherichia coli urinary isolates from outpatients.BMC Fam Pract. 2013 Feb 22;14:25. doi: 10.1186/1471-2296-14-25. BMC Fam Pract. 2013. PMID: 23433241 Free PMC article.
References
-
- Brown PD, Freeman A, Foxman B. 2002. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Clin. Infect. Dis. 34:1061–1066 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical